Nuvation Bio (NUVB)
Develops cancer medicines led by IBTROZI and a focused oncology pipeline.
$6.10
After hours0.00 (0.00%)
At close$6.10(+0.49%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 41 days
EPS estimate
−$0.12
Revenue estimate
$35.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.15−$0.16−$0.17−$0.16−$0.11$0.01−$0.15Pending
Estimate−$0.14−$0.16−$0.17−$0.17−$0.11−$0.03−$0.14−$0.12
Surprise−7.1%0.0%0.0%+5.9%0.0%+135.7%−5.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$5.7M$3.1M$4.8M$13.1M$41.9M$83.2M$31.7MPending
Estimate$833.3K$357.1K$3.6M$36.8M$37.8M$66.2M$27.0M$35.3M
Surprise+585.3%+763.5%+33.4%−64.4%+10.7%+25.7%+17.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.02 | — | — |
| Sep 2027 | −$0.04 | — | — |
| Jun 2027 | −$0.05 | — | — |
| Mar 2027 | −$0.04 | — | — |
| Dec 2026 | −$0.11 | — | — |
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.14 | −$0.15 | −5.9% |
| May 2026 | −$0.03 | $0.01 | +135.7% |
| Mar 2026 | −$0.11 | −$0.11 | 0.0% |
| Nov 2025 | −$0.17 | −$0.16 | +5.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Aug 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.02 | — | — | $74.8M | — | — | — |
| Sep 2027 | −$0.04 | — | — | $64.0M | — | — | — |
| Jun 2027 | −$0.05 | — | — | $62.1M | — | — | — |
| Mar 2027 | −$0.04 | — | — | $60.9M | — | — | — |
| Dec 2026 | −$0.11 | — | — | $46.6M | — | — | — |
| Nov 2, 2026 | −$0.12 | — | — | $35.3M | — | — | — |
| Aug 6, 2026 | −$0.14 | −$0.15 | −5.9% | $27.0M | $31.7M | +17.2% | −4.1% |
| May 4, 2026 | −$0.03 | $0.01 | +135.7% | $66.2M | $83.2M | +25.7% | +9.5% |
| Mar 2, 2026 | −$0.11 | −$0.11 | 0.0% | $37.8M | $41.9M | +10.7% | −25.3% |
| Nov 3, 2025 | −$0.17 | −$0.16 | +5.9% | $36.8M | $13.1M | −64.4% | −6.6% |
| Aug 7, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 14, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Jan 20, 2021 | |||||||
| Aug 14, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |